Structure-activity relationships of novel hematoregulatory peptides

被引:37
作者
Bhatnagar, PK
Agner, EK
Alberts, D
Arbo, BE
Callahan, JF
Cuthbertson, AS
Engelsen, SJ
Fjerdingstad, H
Hartmann, M
Heerding, D
Hiebl, J
Huffman, WF
Hysben, M
King, AG
Kremminger, P
Kwon, C
LoCastro, S
Lovhaug, D
Pelus, LM
Petteway, S
Takata, JS
机构
[1] SMITHKLINE BEECHAM PHARMACEUT, DEPT MOL VIROL & HOST DEF, KING OF PRUSSIA, PA 19406 USA
[2] NYCOMED PHARMA AS, OSLO, NORWAY
[3] HAFSLUND NYCOMBED PHARMA AG, A-4021 LINZ, AUSTRIA
关键词
D O I
10.1021/jm960099d
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Hematopoiesis is a lifelong cell renewal process regulated by a family of lineage specific hematopoietic growth factors. Several hematopoietic growth factors such as G-CSF, GM-CSF, and M-CSF have been clinically evaluated for enhancement of host defense in normal and immunocompromised patients and for the treatment of infectious diseases, This paper reports the structure-activity relationships of low molecular weight hematoregulatory peptides based ori a nonapeptide (1, SK&F 107647). Like the macromolecular growth. factors, these peptides modulate host defense. A molecular target for this class of compounds has not yet been identified. However, the structure-activity relationships established by this study implicate a very specific molecular recognition event that is pivotal for the biological activities of 1 and its analogues.
引用
收藏
页码:3814 / 3819
页数:6
相关论文
共 28 条
  • [1] ALBERTS DP, 1993, 13 AM PEPT S, P367
  • [2] Bodansky M., 1984, PRACTICE PEPTIDE SYN, DOI 10.1007/978-3-642-96835-8
  • [3] HEMATOPOIETIC GROWTH-FACTORS FOR THE TREATMENT OF SEVERE CHRONIC NEUTROPENIA
    DALE, DC
    [J]. STEM CELLS, 1995, 13 (02) : 94 - 100
  • [4] EFFICACY OF THE HEMATOREGULATORY PEPTIDE SK-AND-F-107647 IN EXPERIMENTAL SYSTEMIC CANDIDA-ALBICANS INFECTIONS IN NORMAL AND IMMUNOSUPPRESSED MICE
    DEMARSH, PL
    SUCOLOSKI, SK
    FREY, CL
    BHATNAGAR, PK
    KOLTIN, Y
    ACTOR, P
    PETTEWAY, SR
    [J]. IMMUNOPHARMACOLOGY, 1994, 27 (03): : 199 - 206
  • [5] DEMARSH PL, 1995, IN PRESS J INFECT DI
  • [6] DEMETRI G D, 1992, Current Problems in Cancer, V16, P177
  • [7] FREY CL, 1991, 31ST INT C ANT AG CH, P113
  • [8] HEMATOPOIETIC GROWTH AND INHIBITORY FACTORS IN TREATMENT OF MALIGNANCIES - A REVIEW
    HANSEN, F
    [J]. ACTA ONCOLOGICA, 1995, 34 (04) : 453 - 468
  • [9] G-CSF - AN ANTIINFLAMMATORY CYTOKINE
    HARTUNG, T
    VOLK, HD
    WENDEL, A
    [J]. JOURNAL OF ENDOTOXIN RESEARCH, 1995, 2 (03): : 195 - 201
  • [10] HEYWORTH CM, 1993, HAEMOPOIESIS PRACTIC, P37